News | November 12, 2014

Mevion Medical Systems Delivers Proton Accelerator to UF Health Cancer Center

Accelerator is core component of high-tech proton beam therapy system to treat cancer in adults and children

Mevion Medical Systems, proton beam therapy, proton accelarator, Mevian S250

The Mevion S250 accelerator, being lifted by a crane as it is delivered to the UF Health Cancer Center. Photo: Orlando Health

Nov. 12, 2014 — Mevion Medical Systems will deliver  its Mevion S250 proton therapy superconducting synchrocyclotron accelerator to the University of Florida Health Cancer Center at Orlando Health. The accelerator will treat cancer in adults and children.

Proton therapy precisely delivers radiation doses to tumors while sparing much of the surrounding healthy tissue, thus making it ideal for treating pediatric patients, as well as adult cancers in sensitive locations such as near the heart or brain. As Central Florida’s most advanced cancer center, the UF Health Cancer Center – Orlando Health is the first hospital in the region to install a proton therapy system. Installation of the accelerator will take just a few days, and construction of the proton center is expected to be completed next year.

The MEVION S250 is a proton therapy platform. It requires less space and has lower capital and operational costs than traditional systems. Also, it is a flexible solution; any health care organization can install one single-room Mevion proton thereapy system, or as many as they need to treat their patient population.

Like the rest of the Mevion S250 system, the accelerator itself is highly advanced, compact, patented technology. Due to its small size, it is the only proton beam cyclotron accelerator that can easily be delivered and installed. Consequently, its journey from Mevion’s Boston area headquarters to Orlando was a simple drive down I-95. Designed and manufactured in the United States, the accelerator delivered to Orlando is one of only six in the entire world.

The first Mevion S250 was installed last December at the Kling Center for Proton Therapy at Barnes-Jewish Hospital at Washington University in St. Louis, Mo., and is already treating more than 20 pediatric and adult cancer patients per day. The system is running with 97% uptime.

Five additional Mevion S250s are under installation at Robert Wood Johnson University Hospital in New Brunswick, N.J.; Stephenson Cancer Center at the University of Oklahoma in Oklahoma City, Okla.; Ackerman Cancer Center in Jacksonville, Fla.; University Hospitals Seidman Cancer Center in Cleveland, Ohio; and MedStar Georgetown University Hospital in Washington, D.C.

For more information: www.mevion.com

Related Content

Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers. #ASTRO18 #ASTRO2018

A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers.

Feature | Proton Therapy | November 01, 2018 | Dave Fornell, Editor
A few of the big takeaways from the American Societ...
Victoria Advisory Committee for Proton Therapy Launched at ASTRO 2018
News | Proton Therapy | October 29, 2018
At the 2018 American Society for Radiation Oncology (ASTRO) annual meeting, IBA announced the launch of the Victoria...
Beaumont Hospital Cancer Institute Performs First Irradiation of Spot Scanning Proton Arc Therapy Plan
News | Proton Therapy | October 25, 2018
IBA announced the first irradiation of a Spot Scanning Proton Arc (SPArc) plan at the Beaumont Health Proton Therapy...
Varian Introduces New ProBeam 360° Proton Therapy System
News | Proton Therapy | October 23, 2018
Varian announced its new single-room proton therapy system, ProBeam 360°, at the 2018 American Society of Radiation...
Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018

Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018.

Feature | Stereotactic Body Radiation Therapy (SBRT) | October 23, 2018 | By Greg Freiherr
With its shorter course of treatment,...
IBA's Proteus system and proton therapy solutions will be discussed at ASTRO 2018. #ASTRO18 #ASTRO #ASTRO2018
News | Proton Therapy | October 19, 2018
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and t